PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2) Peptide
PMS2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all PMS2 products
- PMS2 (PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- INKKVVPLDF SMSSLAKRIK QLHHEAQQSE GEQNYRKFRA KICPGENQAA
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PMS2 antibody,
Alternative Names: PMS2 control peptide, PMS2 antibody Blocking Peptide, Anti-PMS2 Blocking Peptide, Pms2 Postmeiotic Segregation Increased 2 Blocking Peptide, HNPCC4 Blocking Peptide, PMS2CL Blocking Peptide, PMSL2 Blocking Peptide, PMS2, PMS-2, PMS 2, PMS-2 Blocking Peptide, PMS 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PMS2 (PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2))
- Background
- PMS2 is involved in DNA mismatch repair. It forms a heterodimer with MLH1 and this complex interacts with other complexes bound to mismatched bases. Mutations in this gene are associated with hereditary nonpolyposis colorectal cancer, Turcot syndrome, and are a cause of supratentorial primitive neuroectodermal tumors.
- Molecular Weight
- 96 kDa
-
You are here:
